CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project addresses Treatment Resistant Depression by identifying genetic variants that influence treatment outcomes. It combines advanced genetic analysis with clinical data to develop a genomic profile, aiming to improve personalized treatment strategies for patients with major depressive disorder.
This project will address the emerging healthcare problem of Treatment Resistant Depression (TRD).
Major Depressive Disorder (MDD) is a major social and clinical burden, responsible for ~15% of all days lived with disability in EU.
Treatment challenges arise from the different biological dysfunctions implicated in different patients and the lack of biomarkers available to guide the choice of anti-depressants.
Preliminary evidence suggests that genetic variants may be useful in making treatment c…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
